Particularly, PC patients with high IRF6 expression had both poor overall survival (HR = 1.6, p = 0.03) (Fig. 4A) and poor disease-free survival (HR = 1.6, p = 0.028) (Fig. 4B). Here, IRF6 is linked to pachyonychia congenita.